U. Balijapalli, S. K. Iyer
FULL PAPER
5 H), 7.85–7.83 (dd, J = 16.0, 4.0 Hz, 1 H), 7.98–7.96 (d, J =
4.0 Hz, 2 H), 8.00 (s, 1 H), 8.04–8.03 (d, J = 4.0 Hz, 1 H), 14.91
(400 MHz, CDCl3): δ = 7.08–7.04 (t, J = 8.0 Hz, 1 H), 7.25–7.23
(d, J = 8.0 Hz, 1 H), 7.67–7.53 (m, 7 H), 7.99–7.91 (m, 3 H), 8.11
(s, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 117.3, 118.4, (s, 1 H), 9.07–9.05 (d, J = 8.0 Hz, 1 H) ppm. 13C NMR (100 MHz,
118.7, 118.9, 120.7, 122.8, 126.5, 127.0, 128.0, 128.9, 129.0, 129.3,
129.6, 132.3, 132.5, 133.7, 137.2, 144.0, 149.3, 157.8, 161.0, 161.1,
163.0 ppm. HRMS: m/z calcd. for C21H14BrNO [M+] 375.0259;
found 375.0259.
CDCl3): δ = 117.5, 120.3, 120.4, 125.0, 126.6, 126.7, 126.8, 127.8,
129.0, 129.3, 129.9, 132.6, 135.5, 136.4, 151.9, 155.3, 156.3 ppm.
11B NMR (128 MHz, CDCl3): δ = 1.57 (s, BF2) ppm. 19F NMR
(376 MHz, CDCl3): δ = –(132.50–132.44) (2 F) ppm. HRMS: m/z
calcd. for C21H14BF2NO [M+] 345.1137; found 345.1131.
2-(6-Methoxy-4-phenylquinolin-2-yl)phenol (4j): Yellow solid; m.p.
144–146 °C. IR (KBr): ν = 3266, 3088, 3043, 2999, 2943, 2331,
˜
8,8-Difluoro-15-phenyl-8H-benzo[h]benzo[5,6][1,3,2]oxazaborinino-
[3,4-a]quinolin-7-ium-8-uide (5b): Yellow solid; m.p. Ͼ300 °C. IR
1778, 1620, 1585, 1543, 1506, 1494, 1386, 1267, 1215, 1120, 1029,
1
906, 887, 754, 698, 624, 590 cm–1. H NMR (400 MHz, CDCl3): δ
(KBr): ν = 3053, 3015, 2926, 2854, 2313, 1737, 1620, 1581, 1512,
˜
= 3.80 (s, 3 H), 6.94–6.90 (t, J = 8.0 Hz, 1 H), 7.09–7.07 (d, J =
8.0 Hz, 1 H), 7.17–7.16 (d, J = 4.0 Hz, 1 H), 7.35–7.31 (t, J =
8.0 Hz, 1 H), 7.42–7.38 (dd, J = 16.0, 4.0 Hz, 1 H), 7.57–7.53 (m,
5 H), 7.91 (s, 1 H), 7.93–7.92 (d, J = 4.0 Hz, 1 H), 8.01–7.99 (d, J
= 8.0 Hz, 1 H), 15.13 (s, 1 H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 55.5, 104.2, 117.9, 118.5, 118.7, 119.1, 122.4, 126.3, 126.6,
128.7, 128.8, 129.2, 129.4, 131.5, 138.2, 141.1, 148.8, 155.1, 158.1,
160.7 ppm. HRMS: m/z calcd. for C22H17NO2 [M+] 327.1259;
found 327.1259.
1
1384, 1294, 1112, 1080, 958, 902, 869, 852, 756, 705, 675 cm–1. H
NMR (400 MHz, CDCl3): δ = 6.80–6.76 (t, J = 8.0 Hz, 1 H), 6.92–
6.90 (d, J = 8.0 Hz, 1 H), 7.20–7.16 (t, J = 8.0 Hz, 1 H), 7.60–7.39
(m, 9 H), 7.77–7.75 (d, J = 8.0 Hz,1 H), 7.84–7.82 (d, J = 8.0 Hz,1
H), 7.92 (s, 1 H), 8.77–8.75 (d, J = 8.0 Hz, 1 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 108.7, 118.8, 120.2, 122.5, 123.5, 126.5,
127.2, 128.1, 129.4, 129.7, 133.3, 136.8, 145.0, 154.3, 170.9 ppm.
11B NMR (128 MHz, CDCL3): δ = –1.16 (s, BF2) ppm. 19F NMR
(376 MHz, CDCl3): δ = –(148.45–148.38) (2 F) ppm. HRMS: m/z
calcd. for C25H16BF2NO [M+] 395.1293; found 395.1399.
2-(6-Methyl-4-phenylquinolin-2-yl)phenol (4k): Yellow solid; m.p.
168–170 °C. IR (KBr): ν = 3250, 3089, 3047, 2926, 2858, 2330,
˜
6,6-Difluoro-8-methoxy-13-phenyl-6H-benzo[5,6][1,3,2]oxaza-
borinino[3,4-a]quinolin-5-ium-6-uide (5c): Yellow solid; m.p. 247–
1741, 1583, 1546, 1490, 1355, 1246, 1124, 1076, 962, 871, 752, 744,
705, 594 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.46 (s, 3 H),
6.94–6.90 (t, J = 8.0 Hz, 1 H), 7.09–7.07 (d, J = 8.0 Hz, 1 H), 7.36–
7.32 (t, J = 4.0 Hz, 1 H), 7.57–7.53 (m, 6 H), 7.61 (s, 1 H), 7.91 (s,
1 H), 7.94–7.92 (d, J = 4.0 Hz, 1 H), 7.99–7.97 (d, J = 8.0 Hz, 1
H), 15.30 (s, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 21.8,
117.6, 118.5, 118.6, 119.1, 121.0, 124.6, 125.3, 126.8, 127.7, 128.6,
128.7, 129.4, 130.0, 131.8, 132.4, 136.8, 138.1, 143.7, 149.5, 156.5,
161.0, 161.7 ppm. HRMS: m/z calcd. for C22H17NO [M+] 311.1310;
found 311.1316.
249 °C. IR (KBr): ν = 3053, 3005, 2903, 2835, 2346, 1743, 1604,
˜
1554, 1519, 1460, 1386, 1363, 1234, 1080, 1062, 1039, 935, 767,
727, 704 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.99 (s, 3 H),
6.99–6.95 (t, J = 8.0 Hz, 1 H), 7.10–7.08 (d, J = 8.0 Hz, 1 H), 7.54–
7.52 (d, J = 8.0 Hz, 1 H), 7.66–7.56 (m, 6 H), 7.97–7.89 (m, 2 H),
8.08 (s, 1 H), 9.09–9.07 (d, J = 8.0 Hz, 1 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 56.2, 115.8, 118.0, 119.9, 125.0, 125.1,
126.1, 126.6, 126.8, 127.8, 128.9, 129.0, 129.3, 129.4, 129.8, 132.5,
136.4, 140.8, 150.2, 152.0, 155.2 ppm. 11B NMR (128 MHz,
CDCl3): δ = 1.68 (s, BF2) ppm. 19F NMR (376 MHz, CDCl3): δ
= –(132.06–131.99) (2 F) ppm. HRMS: m/z calcd. for
C22H16BF2NO2 [M+] 375.1242; found 375.1249.
2-(5,7-Dimethyl-4-phenylquinolin-2-yl)phenol (4l): Yellow solid; m.p.
149–151 °C. IR (KBr): ν = 3290, 3142, 3057, 2978, 2861, 2328,
˜
1735, 1597, 1494, 1411, 1381, 1363, 1300, 1222, 1153, 765, 756,
1
868, 659, 619, 588 cm–1. H NMR (400 MHz, CDCl3): δ = 2.00 (s,
3 H), 2.54 (s, 3 H), 6.94–6.90 (t, J = 8.0 Hz, 1 H), 7.12–7.10 (d, J
= 8.0 Hz, 1 H), 7.14 (s, 1 H), 7.40–7.28 (m, 3 H), 7.52–7.49 (m, 3
H), 7.79–7.77 (d, J = 8.0 Hz, 2 H), 7.92–7.90 (d, J = 8.0 Hz, 1 H),
15.44 (s, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 21.4, 24.1,
118.5, 118.5, 118.7, 118.7, 118.9, 122.8, 125.9, 126.8, 128.0, 128.0,
128.6, 131.8, 132.3, 135.3, 140.1, 142.4, 146.6, 150.4, 155.9,
161.2 ppm. HRMS: m/z calcd. for C23H19NO [M+] 325.1467; found
325.1469.
8-Ethoxy-6,6-difluoro-13-phenyl-6H-benzo[5,6][1,3,2]oxazaborinino-
[3,4-a]quinolin-5-ium-6-uide (5d): Yellow solid; m.p. 240–242 °C. IR
(KBr): ν = 3047, 2972, 2926, 2328, 1737, 1595, 1442, 1388, 1363,
˜
1234, 1095, 1074, 1053, 962, 918, 873, 769, 723, 698 cm–1. 1H NMR
(400 MHz, CDCl3): δ = 1.57–1.53 (t, J = 8.0 Hz, 1 H), 4.26–4.20
(q, J = 8.0 Hz, 2 H), 6.98–6.94 (t, J = 8.0 Hz, 1 H), 7.12–7.10 (d,
J = 8.0 Hz, 1 H), 7.55–7.53 (d, J = 8.0 Hz, 1 H), 7.66–7.57 (m, 6
H), 7.98–7.90 (m, 2 H), 8.08 (s, 1 H), 9.09–9.07 (d, J = 8.0 Hz, 1
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 14.8, 65.0, 114.9, 117.9,
118.0, 118.1, 118.3, 119.9, 125.0, 125.9, 126.6, 126.8, 127.1, 127.8,
128.8, 129.0, 129.3, 129.4, 129.8, 132.5, 136.4, 152.1, 155.1 ppm.
11B NMR (128 MHz, CDCl3): δ = 1.67 (s, BF2) ppm. 19F NMR
(376 MHz, CDCl3): δ = –(132.25–132.32) (2 F) ppm. HRMS: m/z
calcd. for C23H18BF2NO2 [M+] 389.1399; found 389.1399.
General Procedure for the Preparation of 5a–m: To a stirred solution
of 2-(4-phenylquinolin-2-yl)phenol (1 mmol) in anhydrous di-
chloromethane (10 mL) at room temperature was added boron tri-
fluoride–diethyl ether complex (2.5 mmol). A color change oc-
curred or a precipitate appeared, revealing the formation of an in-
termediate adduct. Triethylamine (1.0 mmol) was then added to the
solution, which was stirred at room temperature for 12–18 h. The
course of the reaction was monitored by TLC analysis and, upon
completion of the reaction, water was added to the solution. The
solution was extracted with CH2Cl2 and the organic layer was
washed with water and dried with MgSO4. After concentration of
solvent, the residue was purified by column chromatography with
silica gel (CH2Cl2/n-hexane) to afford 5a (52 mg, 97%) as a yellow
solid.
10-Bromo-6,6-difluoro-13-phenyl-6H-benzo[5,6][1,3,2]oxaza-
borinino[3,4-a]quinolin-5-ium-6-uide (5e): Yellow solid; m.p. 292–
294 °C. IR (KBr): ν = 3093, 3057, 2991, 2366, 1734, 1622, 1593,
˜
1467, 1392, 1354, 1249, 1205, 1101, 1001, 933, 871, 812, 759, 704,
680, 626, 597 cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.04–7.02 (t,
J = 8.0 Hz, 1 H), 7.48–7.45 (dd, J = 16.0, 4.0 Hz, 1 H), 7.67–7.55
(m, 5 H), 7.83–7.79 (t, J = 8.0 Hz, 1 H), 7.92 (s, 1 H), 7.95–7.93
(d, J = 8.0 Hz, 1 H), 8.07–8.06 (dd, J = 4.0 Hz, 1 H), 8.16–8.14 (d,
J = 8.0 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 117.4,
120.5, 126.0, 127.1, 127.7, 128.8, 129.0, 129.4, 130.7, 134.7,
6,6-Difluoro-13-phenyl-6H-benzo[5,6][1,3,2]oxazaborinino[3,4-a]-
quinolin-5-ium-6-uide (5a): Yellow solid; m.p. 252–254 °C. IR
(KBr): ν = 3055, 3026, 2922, 2852, 2333, 1717, 1604, 1550, 1267, 155.9 ppm. 11B NMR (128 MHz, CDCL3): δ = 1.51 (s, BF2) ppm.
˜
1101, 1073, 1002, 871, 837, 750, 742, 702, 663 cm–1
.
1H NMR 19F NMR (376 MHz, CDCl3): δ = –(132.38–132.44) (2 F) ppm.
5096
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 5089–5098